Volume 119, Issue 5, Pages (November 2000)

Slides:



Advertisements
Similar presentations
Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.
Advertisements

Serum immunoglobulin a from patients with celiac disease inhibits human T84 intestinal crypt epithelial cell differentiation Tuula Halttunen, Markku Mäki.
Interleukin 15 mediates epithelial changes in celiac disease Luigi Maiuri, Carolina Ciacci, Salvatore Auricchio, Virginia Brown, Sonia Quaratino, Marco.
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.
Volume 354, Issue 9180, Pages (August 1999)
Volume 48, Issue 4, Pages (April 2011)
Copyright © 2015 by the American Osteopathic Association.
This patient has a lumbar spine (L1-L4) bone mineral density (BMD) of g/cm2 (cross on the reference database graph) measured by dual-energy x-ray.
Volume 103, Pages (October 2017)
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn’s disease  Erik J. Schoon, Simona Bollani, Peter.
Sharon H. Chou, Jessica Hwang, Siu-Ling Ma, Tamara Vokes 
Bone Disease in Patients With Primary Sclerosing Cholangitis
Volume 120, Issue 4, Pages (March 2001)
The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection  R. Singh, M. Nieuwdorp, I.J.M.
Diagnosis of irritable bowel syndrome
Lactose malabsorption and intolerance and peak bone mass
Diagnosis of celiac sprue
Bone mineral density and body composition after laparoscopic sleeve gastrectomy in men: A short-term longitudinal study  Piotr Adamczyk, Marek Bužga,
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?  William E. Whitehead, Olafur.
Bone mineral density in relation to efficacy and side effects of budesonide and prednisolone in Crohn’s disease  Erik J. Schoon, Simona Bollani, Peter.
Volume 117, Issue 5, Pages (November 1999)
Sharon H. Chou, Jessica Hwang, Siu-Ling Ma, Tamara Vokes 
Trends in Overall and Cause-Specific Mortality Among Patients With Inflammatory Bowel Disease From 1982 to 2010  Tine Jess, Morten Frisch, Jacob Simonsen 
Volume 124, Issue 4, Pages (April 2003)
Osteoporosis in inflammatory bowel disease
Spreading and focusing of gluten epitopes in celiac disease
Significance of pelvic floor muscles in anal incontinence
Volume 120, Issue 4, Pages (March 2001)
Appendectomy is followed by increased risk of Crohn's disease
Short-Bowel Syndrome Clinical Gastroenterology and Hepatology
Country-Specific Young Adult Dual-Energy X-Ray Absorptiometry Reference Data Are Warranted for T-Score Calculations in Women: Data From the Peak-25 Cohort 
Type of Hip Fracture in Patients With Parkinson Disease is Associated With Femoral Bone Mineral Density  Marco Di Monaco, MD, Fulvia Vallero, MD, Roberto.
Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991–2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms  Mariëlle.
Volume 123, Issue 5, Pages (November 2002)
Volume 120, Issue 4, Pages (March 2001)
Risk of Nonmelanoma Skin Cancer in Patients With Inflammatory Bowel Disease Who Use Thiopurines Is Not Increased  Fiona D.M. van Schaik, Martijn G.H.
Volume 123, Issue 2, Pages (August 2002)
Francisco A. Sylvester, Scott Leopold, Miriam Lincoln, Jeffrey S
Volume 119, Issue 1, Pages (July 2000)
Volume 66, Issue 5, Pages (November 2004)
Reenu Malhotra, Kevin Turner, Amnon Sonnenberg, Robert M. Genta 
Volume 133, Issue 6, Pages (December 2007)
Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud 
AGA technical review on nonalcoholic fatty liver disease
AGA technical review on celiac sprue
Volume 121, Issue 5, Pages (November 2001)
Risk of Cerebrovascular Accidents and Ischemic Heart Disease in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis  Siddharth.
Rectal Mucosal Nitric Oxide in Differentiation of Inflammatory Bowel Disease and Irritable Bowel Syndrome  Claudia I. Reinders, Max Herulf, Tryggve Ljung,
Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome  Janet Hegarty, M. Zulf Mughal, Judith.
Disordered Eating, Menstrual Disturbances, and Low Bone Mineral Density in Dancers: A Systematic Review  Cesar A. Hincapié, DC, MHSc, J. David Cassidy,
Volume 140, Issue 6, Pages e2 (May 2011)
Diagnosing pancreatic malignancy in the setting of chronic pancreatitis: is there room for improvement?  James J. Farrell, MD  Gastrointestinal Endoscopy 
Volume 115, Issue 4, Pages (October 1998)
Volume 114, Issue 5, Pages (May 1998)
AGA technical review on osteoporosis in gastrointestinal diseases
Volume 63, Issue 2, Pages (February 2003)
Incidence of Neoplasms in Patients Who Develop Sustained Leukopenia During or After Treatment With 6-Mercaptopurine for Inflammatory Bowel Disease  William.
Inflammatory Bowel Disease in African American Children Compared With Other Racial/Ethnic Groups in a Multicenter Registry  Jolanda M. White, Siobhán.
Mesalamine and relapse prevention in Crohn's disease
Michelle Maria Pietzak  Gastroenterology 
M. Kathleen Clark, Ph. D. , MaryFran R. Sowers, Ph. D
H.J. Heller, J.E. Zerwekh, F.A. Gottschalk, C.Y.C. Pak 
Surgery for Obesity and Related Diseases
Hepatic deficiency of interleukin 10 in chronic hepatitis C
David S. Fefferman, Richard J. Farrell 
Physical Function in Patients with Cancer
Volume 121, Issue 4, Pages (October 2001)
Volume 57, Issue 2, Pages (October 2000)
Volume 120, Issue 4, Pages (March 2001)
Coping Strategies and Interpersonal Support in Patients With Irritable Bowel Syndrome and Inflammatory Bowel Disease  Michael P. Jones, Sarah Wessinger,
Presentation transcript:

Volume 119, Issue 5, Pages 1203-1208 (November 2000) Bone mineral density in patients with recently diagnosed inflammatory bowel disease  Erik J. Schoon, Barbara M. Blok, Bertine J. Geerling, Maurice G. Russel, Reinhold W. Stockbrügger, Robert–Jan M. Brummer  Gastroenterology  Volume 119, Issue 5, Pages 1203-1208 (November 2000) DOI: 10.1053/gast.2000.19280 Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 1 BMD (g/cm2) at different sites of measurement in patients with IBD compared with control subjects. Lines indicate median values. No significant differences were found between IBD patients and controls. Paired differences of mean and 95% confidence intervals (CIs) of the difference were calculated. BMD of total body: mean, 2.25 × 10−2; SD, 0.11; 95% CI, –5.6 × 10−3 to −5.06 × 10−2; patients vs. controls. BMD at lumbar spine: mean, –4.4 × 10−3; SD, 0.174; 95% CI, −5.4 × 10−2 to −4.47 ×10−2; patients vs. controls. BMD at femoral neck: mean, 2.65; SD, 0.186; 95% CI, −4.9 ×10−2 to 5.46 ×10−2; patients vs. controls. Gastroenterology 2000 119, 1203-1208DOI: (10.1053/gast.2000.19280) Copyright © 2000 American Gastroenterological Association Terms and Conditions

Fig. 2 BMD (Z score) at different sites of measurement in patients with CD compared with UC. Lines indicate median values. No significant differences were found between CD and UC patients. Gastroenterology 2000 119, 1203-1208DOI: (10.1053/gast.2000.19280) Copyright © 2000 American Gastroenterological Association Terms and Conditions